Clinical Trial Update: Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating targeted radiotherapy in hematopoietic stem cell transplantation for poor risk hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukaemia
• Lymphoma
• Myeloma

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Acute Leukaemia, Chronic Leukaemia | Phase 1, Phase 2 | Status: COMPLETED